Clinical presentation, diagnosis, and treatment of chronic granulomatous disease
Open Access
- 28 June 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 12, 1384550
Abstract
Chronic granulomatous disease (CGD) is caused by an impaired respiratory burst reaction in phagocytes. CGD is an X-linked (XL) (caused by pathogenic variants in CYBB) or autosomal recessive inborn error of immunity (caused by pathogenic variants in CYBA, NCF1, NCF2, or CYBC1). Female carriers of XL-CGD and unfavorable lyonization may present with the partial or full picture of CGD. Patients with CGD are at increased risk for invasive bacterial and fungal infections of potentially any organ, but especially the lymph nodes, liver, and lungs. Pathogens most frequently isolated are S. aureus and Aspergillus spp. Autoinflammation is difficult to control with immunosuppression, and patients frequently remain dependent on steroids. To diagnose CGD, reactive oxygen intermediates (O2− or H2O2) generated by the NADPH oxidase in peripheral blood phagocytes are measured upon in vitro activation with either phorbol-12-myristate-13-acetate (PMA) and/or TLR4 ligands (E. coli or LPS). Conservative treatment requires strict hygienic conduct and adherence to antibiotic prophylaxis against bacteria and fungi, comprising cotrimoxazole and triazoles. The prognosis of patients treated conservatively is impaired: for the majority of patients, recurrent and/or persistent infections, autoinflammation, and failure to thrive remain lifelong challenges. In contrast, cellular therapies (allogeneic stem cell transplantation or gene therapy) can cure CGD. Optimal outcomes in cellular therapies are observed in individuals without ongoing infections or inflammation. Yet cellular therapies are the only curative option for patients with persistent fungal infections or autoinflammation.Keywords
This publication has 132 references indexed in Scilit:
- Primary immunodeficiency diseases of adults: a review of pulmonary complication imaging findingsEuropean Radiology, 2023
- Health Related Quality of Life and Emotional Health in Children with Chronic Granulomatous Disease: A Comparison of Those Managed Conservatively with Those That Have Undergone Haematopoietic Stem Cell TransplantJournal of Clinical Immunology, 2012
- Inflammation and repeated infections in CGD: two sides of a coinCellular and Molecular Life Sciences, 2011
- Successful unrelated bone marrow transplantation in a child with chronic granulomatous disease complicated by pulmonary and cerebral granuloma formationEuropean Journal of Pediatrics, 2006
- NADPH oxidase is not required for spontaneous and Staphylococcus aureus-induced apoptosis of monocytesAnnals of Hematology, 2004
- Klinisches Bild, Diagnostik und Therapie granulomatöser Entzündungen ohne Erregernachweis bei 6 Patienten mit septischer Granulomatose (CGD)Monatsschrift Kinderheilkunde, 2003
- Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditionsCytometry, 1994
- Chronic granulomatous disease 100% corrected by displacement bone marrow transplantation from a volunteer unrelated donorEuropean Journal of Pediatrics, 1992
- Chronic Granulomatous Disease in Three Female SiblingsJAMA, 1968
- A Fatal Granulomatous Disease of ChildhoodA.M.A. Journal of Diseases of Children, 1959